Karen Magraith
Research Subjects
Research Interests
Karen Magraith has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Bronwyn Stuckey
Keogh Inst Med Res, Nedlands, WA, Australia
2 shared publicationsAmanda Vincent
MBBS, BMedSci (Hons), PhD, FRACP, Head, Early Menopause research, Monash Centre for Health Research and Implementation (MCHRI), School of Public Health and Preventive Medicine, Monash University @ in partnership with Monash Health, Melbourne, Vic; Early Menopause Research Stream Lead, Centre for Research Excellence in Women@s Health in Reproductive Life, Melbourne, Vic; Endocrinologist, Department of Endocrinology, Monash Health, Melbourne, Vic
1 shared publicationBelinda E Kiely
MBBS, FRACP, PhD, Senior Staff Specialist , Department of Medical Oncology, Campbelltown Hospital, Sydney, NSW; Senior Staff Specialist , Department of Medical Oncology, Concord Hospital, Sydney, NSW; Clinical Research Fellow, NHMRC Clinical Trials Centre, The University of Sydney, Sydney, NSW
1 shared publicationChristina Jang
MBBS, MD, FRACP, Senior Lecturer, Faculty of Medicine, The University of Queensland, Qld; Endocrinologist, Queensland Diabetes and Endocrine Centre, Mater Health, Qld
1 shared publicationKun Zhu
Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Nedlands, WA, Australia
1 shared publicationNicole Opie
Keogh Inst Med Res, Nedlands, WA, Australia
1 shared publication
Latest Publications
- 1 May 2024
- Published by The Royal Australian College of General Practitioners in Australian Journal of General Practice
- Vol. 53 (5) , 305-310
Safety of vaginal oestrogens for genitourinary symptoms in women with breast cancer
This article provides a summary of the data on the safety of vaginal oestrogens in women with breast cancer to help GPs advise their patients in this situation.
- 1 May 2024
- Published by The Royal Australian College of General Practitioners in Australian Journal of General Practice
- Vol. 53 (5) , 305-310
Safety of vaginal oestrogens for genitourinary symptoms in women with breast cancer
This article provides a summary of the data on the safety of vaginal oestrogens in women with breast cancer to help GPs advise their patients in this situation.
- 1 February 2023
- Published by The Royal Australian College of General Practitioners in Australian Journal of General Practice
- Vol. 52 (1-2) , 32-38
Premature ovarian insufficiency and infertility
This article provides an overview of the diagnosis of premature ovarian insufficiency and its management with respect to infertility.
- 1 February 2023
- Published by The Royal Australian College of General Practitioners in Australian Journal of General Practice
- Vol. 52 (1-2) , 32-38
Premature ovarian insufficiency and infertility
This article provides an overview of the diagnosis of premature ovarian insufficiency and its management with respect to infertility.
- 1 March 2021
- Published by The Royal Australian College of General Practitioners in Australian Journal of General Practice
- Vol. 50 (3) , 165-170
Fracture risk prediction and the decision to treat low bone density
A calculation of absolute fracture risk is commonly provided with bone mineral density reports in Australia, usually using either FRAX (Australia) or Garvan Fracture Risk Calculator (Garvan).
- 1 March 2021
- Published by The Royal Australian College of General Practitioners in Australian Journal of General Practice
- Vol. 50 (3) , 165-170
Fracture risk prediction and the decision to treat low bone density
A calculation of absolute fracture risk is commonly provided with bone mineral density reports in Australia, usually using either FRAX (Australia) or Garvan Fracture Risk Calculator (Garvan).
- 1 July 2019
- Published by The Royal Australian College of General Practitioners in Australian Journal of General Practice
- Vol. 48 (7) , 457-462
Making choices at menopause
Menopause is a time of change in women's lives and an opportunity for health promotion. Women can present with a range of symptoms and concerns. The aim of this article is to review the key components of the assessment of women who are perimenopausal or menopausal, and to discuss the benefits and risks of hormonal and non-hormonal treatments, thereby assisting clinicians to appropriately manage these women. The majority of women who are symptomatic can be offered menopausal hormone therapy (MHT). To ensure women can make an informed choice about whether to use MHT, it is important for them to receive balanced and accurate information about the benefits and risks. For women with contraindications to MHT, or women who prefer not to use hormones, non-hormonal and complementary options may be considered. New non-hormonal options are likely to be available in the future.
- 1 July 2019
- Published by The Royal Australian College of General Practitioners in Australian Journal of General Practice
- Vol. 48 (7) , 457-462
Making choices at menopause
Menopause is a time of change in women's lives and an opportunity for health promotion. Women can present with a range of symptoms and concerns. The aim of this article is to review the key components of the assessment of women who are perimenopausal or menopausal, and to discuss the benefits and risks of hormonal and non-hormonal treatments, thereby assisting clinicians to appropriately manage these women. The majority of women who are symptomatic can be offered menopausal hormone therapy (MHT). To ensure women can make an informed choice about whether to use MHT, it is important for them to receive balanced and accurate information about the benefits and risks. For women with contraindications to MHT, or women who prefer not to use hormones, non-hormonal and complementary options may be considered. New non-hormonal options are likely to be available in the future.